Celera Genomics to Provide Database Subscription to University of California System
Deal Includes Researchers at Ten California Campuses and Three U.S. Department of Energy National Laboratories Managed by UC
Rockville, MD - January 29, 2001
Celera Genomics (NYSE: CRA), an Applera Corporation business, announced today it signed a multi-year agreement with the University of California (UC) system allowing UC investigators access to all of Celera’s database products. The UC system encompasses ten campuses throughout California and three national laboratories--Lawrence Berkeley National Laboratory, Lawrence Livermore National Laboratory and Los Alamos National Laboratory. The UC subscribers will access Celera's database information through its Celera Discovery System™. Financial terms of the agreements were not disclosed.
“This agreement with the University of California system is personally very gratifying because I earned my Ph.D. in physiology and pharmacology at UC San Diego in 1975,” said J. Craig Venter, Ph.D., Celera’s president and chief scientific officer. “UC is one of the world’s largest higher education systems whose scientists are recognized leaders in public research. I believe that access to Celera’s online portfolio of comparative genomic and genetic variation information as well as the tools, software and computing power to analyze these data, should advance medical research at UC and worldwide.”
“The faculty of the University of California has a long history of working at the leading edge of science," said UC Provost Judson King. "Celera's genome databases should ensure that our researchers have the best tools to forge the frontiers of comparative genetics, evolution, biochemistry and medicine as well as to educate the future scientific leaders in these disciplines."
The Celera Discovery System is an integrated, web-based discovery system that allows subscribers to use Celera generated databases, additional non-proprietary genome and biological datasets, computational tools and super-computing power to advance the discovery programs of researchers worldwide.
About the Regents of the University of California
With a student body of over 170,000 students and a research budget of approximately $2 billion, the University of California is one of the largest educational and research institutions in the world. The UC system also operates the nation's largest medical research and training program comprised of 14 health science schools located on six campuses.
Applera Corporation, formerly PE Corporation, comprises two operating groups. The Celera Genomics Group, headquartered in Rockville, MD, intends to be the definitive source of genomic and related medical information. Celera has developed three business units: the On-line Information Business, Discovery Sciences, and Discovery Services, all of which build upon Celera’s generation, integration, and analysis of biological information. Celera intends to enable therapeutic discoveries both through its own application of its scientific capabilities and in partnership with pharmaceutical and biotechnology companies. The Applied Biosystems Group (NYSE:ABI) develops and markets instrument-based systems, reagents, software, and contract services to the life science industry and research community. Customers use these tools to analyze nucleic acids (DNA and RNA) and proteins in order to make scientific discoveries, develop new pharmaceuticals, and conduct standardized testing. Applied Biosystems is headquartered in Foster City, CA, and reported sales of $1.4 billion during fiscal 2000. Information about Applera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available on the World Wide Web at www.applera.com, or by telephoning 800.762.6923.
Notice To Readers: Celera's press releases, presentations and printed remarks are included on this website for historical purposes only. The information contained in these documents should be considered accurate only as of the date of the relevant document. This information may change over time, and therefore visitors to this website should not assume that the information contained in these documents remains accurate at a later time. We do not have any current intention to update any of the information in these documents.